MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors
Article in International Journal of Clinical Oncology (April 2024)
The most recent citing publications are shown below. View all 75 publications that cite this research output on Dimensions.
Article in International Journal of Clinical Oncology (April 2024)
Article in Clinical Genitourinary Cancer (April 2024)
Article in Journal of Psychosocial Oncology Research and Practice (November 2023)